484 views | 1 decade ago
Jennifer Stone, Ph.D., Cancer Genomics Market Manager at Illumina, discusses Illumina's view of cancer research and how by continually advancing its technologies it is supporting researchers with tools...
8179 views | 1 decade ago
Kenneth Bloom, MD, FCAP, Chief Medical Officer at Clarient (GE Healthcare), discusses the practical aspects of how next-generation sequencing will be applied in the clinical laboratory.
759 views | 1 decade ago
Jeffrey Miller, Ph.D., CSO and CEO of Invivoscribe, discusses the clinical basis for clonality testing, current technologies to identify clonality and the development of new assays to identify and monitor...
1836 views | 1 decade ago
Illumina Cancer Webinar Series: Gad Getz, Ph.D., founder of the Cancer Genome Computational Analysis group at the Broad Institute and Director of Bioinformatics at the Mass General Cancer Center and...
199 views | 1 decade ago
Considerations for the Development of an Autism Targeted Sequencing Panel with Dr. Jonathan Pevsner
1399 views | 1 decade ago
SynapDx is developing a test to shorten the time from suspicion of autism to diagnosis. They chose Illumina next-generation sequencing technology as the platform for designing performance characteristics...
436 views | 1 decade ago
Discovering a Causal Somatic Mutation in Patients with Sturge-Weber Syndrome with Dr. Jonathan Pevsner
195 views | 1 decade ago